Medical Devices News and Research

RSS

Medical device to reduce frequency of seizures in epilepsy patients gets FDA approval

The U.S. Food and Drug Administration today approved a device to help reduce the frequency of seizures in epilepsy patients who have not responded well to medications.

14 Nov 2013

Groundbreaking study reveals novel approach to treat, eliminate MRSA infection

Recent work from University Distinguished Professor of Biology Kim Lewis promises to overcome one of the leading public health threats of our time. In a groundbreaking study published Wednesday in the journal Nature, Lewis' team presents a novel approach to treat and eliminate methicillin resistant staphylococcus aureus, or MRSA, a potent bacterium whose resistance to antibiotics has kept it one step ahead of researchers.

14 Nov 2013

Derma Sciences third quarter 2013 net sales increase 12% to $22.1 million

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and nine months ended September 30, 2013.

13 Nov 2013

Study highlights disparities in access to diabetes treatment in European countries

Hundreds of thousands of people living with diabetes in Europe do not have access to the treatment they need, putting their health at risk. These are the initial findings of a study by the International Diabetes Federation Europe on Access to Quality Medicines and Medical Devices for Diabetes Care in Europe.

13 Nov 2013

Study outlines “sobering reality” of the U.S. health care system

Over the last decade, the biggest driver of the high health care costs in the United States has been neither the aging of the population nor the large numbers of tests and treatments being prescribed.

13 Nov 2013

Global Coalition Against Child Pneumonia calls for continued investment in innovations, proven tools

Global health advocates today commemorated the fifth annual World Pneumonia Day by calling on global leaders to scale up existing interventions and invest in new diagnostics and treatments to defeat pneumonia. Each year, pneumonia kills more children than AIDS, malaria and tuberculosis combined. Pneumonia took the lives of nearly 1.1 million children under 5 in 2012 alone, with more than 99 percent of these deaths in developing countries, where access to healthcare facilities and treatment is out of reach for many children.

12 Nov 2013

IEEE-SA, Continua partner to broaden adoption of standards-based technologies for healthcare arena

IEEE Standards Association and Continua Health Alliance today announced they have signed a strategic agreement to help accelerate and broaden the adoption of globally relevant standards-based technologies for the healthcare arena.

12 Nov 2013

Avedro initiates US clinical trials for Lasik with cross-linking and pulsed accelerated cross-linking

Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.

12 Nov 2013

ReShape Duo Intragastric Balloon treatment for weight loss meets primary efficacy endpoints

ReShape Medical, Inc. today announced that its REDUCE Trial for the ReShape Duo Intragastric Balloon, a non-surgical treatment for weight loss, has met its primary efficacy endpoints.

11 Nov 2013

Covidien fourth quarter net sales increase 2% to $2.56 billion

Covidien plc today reported results for the fourth quarter of fiscal 2013 (July - September 2013). Fourth-quarter net sales of $2.56 billion increased 2% from the $2.50 billion in the fourth quarter a year ago. Foreign exchange rate movement lowered the quarterly sales growth rate by three percentage points.

8 Nov 2013

New coverage gaps, cost issues spur health law worries

News outlets look at the nuts and bolts of the health law's implementation, including a worry that coverage gaps will persist for some vulnerable people, as well as how the government pays for insurance subsidies and why some premium costs increase under the health law.

8 Nov 2013

Topera receives FDA clearance for FIRMap Catheter

Topera, Inc., a medical device company that has developed a novel mapping and targeting system for the identification of the sources that sustain complex cardiac arrhythmias, today announced that it has received 510(k) clearance by the U.S. Food and Drug Administration for the FIRMap Catheter.

7 Nov 2013

Linagliptin shows efficacy, tolerability in adults with T2D and liver disease

Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.

7 Nov 2013

UCLA launches first university-based military medicine center to care for wounded veterans

UCLA has launched the first university-based military medicine center on the West Coast, thanks to a generous donation from two sons in honor their father, the inventor, entrepreneur and philanthropist Ronald A. Katz.

7 Nov 2013

Sleep Science's new OSA treatment to be presented in WHO Compendium of Innovative Technologies

Sleep Science Partners' mandibular repositioning treatment for obstructive sleep apnea has been accepted for inclusion in the 2013 World Health Organization Compendium of Innovative Technologies to be published this November.

6 Nov 2013

Avedro gets CE Mark clearance for KXL II System

Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces CE Mark clearance for its KXL II System. The KXL II System has the potential for non-surgical correction of myopia, as well as improving cataract surgery outcomes, with a procedure called PiXL (Photorefractive Intrastromal Cross-linking).

5 Nov 2013

Biomedical testing: an interview with Ed Moriarty, General Manager of the ElectroForce Systems Group of Bose Corporation

An interview with Ed Moriarty, discussing how Bose are involved in the development of advanced testing equipment for medical devices.

From TA Instruments 4 Nov 2013

FzioMed receives FDA approval for independent review of PMA for Oxiplex Gel

FzioMed, a medical device company that recently celebrated the 17th anniversary of its founding, has received approval from the Commissioner of the U.S. Food and Drug Administration of its Petition for an independent review of its premarket approval application for Oxiplex Gel.

4 Nov 2013

Protego develops sternal device for cardiac surgery with start-up investment from MRCF

Protego Medical Pty Ltd, an early stage medical technology company developing a medical device for sternal protection during cardiac surgery, was launched today with AU$2M start-up financing from Australia’s Medical Research Commercialisation Fund (MRCF). At the same time, the Company announced the appointment of Pablo Solis as CEO.

31 Oct 2013

Prestigious Janssen Industry Excellence Awards announced

The prestigious Janssen Industry Excellence Awards were announced as part of the official opening reception for the AusBiotech 2013 Conference at Brisbane City Hall last night; among them, internationally-acclaimed Brisbane-based researcher, Professor Ian Frazer.

31 Oct 2013

Medical Devices News and Research

Medical device to reduce frequency of seizures in epilepsy patients gets FDA approval

Groundbreaking study reveals novel approach to treat, eliminate MRSA infection

Derma Sciences third quarter 2013 net sales increase 12% to $22.1 million

Study highlights disparities in access to diabetes treatment in European countries

Study outlines “sobering reality” of the U.S. health care system

Global Coalition Against Child Pneumonia calls for continued investment in innovations, proven tools

IEEE-SA, Continua partner to broaden adoption of standards-based technologies for healthcare arena

Avedro initiates US clinical trials for Lasik with cross-linking and pulsed accelerated cross-linking

ReShape Duo Intragastric Balloon treatment for weight loss meets primary efficacy endpoints

Covidien fourth quarter net sales increase 2% to $2.56 billion

New coverage gaps, cost issues spur health law worries

Topera receives FDA clearance for FIRMap Catheter

Linagliptin shows efficacy, tolerability in adults with T2D and liver disease

UCLA launches first university-based military medicine center to care for wounded veterans

Sleep Science's new OSA treatment to be presented in WHO Compendium of Innovative Technologies

Avedro gets CE Mark clearance for KXL II System

Biomedical testing: an interview with Ed Moriarty, General Manager of the ElectroForce Systems Group of Bose Corporation

FzioMed receives FDA approval for independent review of PMA for Oxiplex Gel

Protego develops sternal device for cardiac surgery with start-up investment from MRCF

Prestigious Janssen Industry Excellence Awards announced

Industry Focus eBook - Medical Devices (3rd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News